Summary
Two angiotensin II analogues (AIIA), 1-sarcosine, 8-isoleucine angiotensin II ([Sar1, Ile8]-AII) and 1-sarcosine, 8-alanine angiotensin II ([Sar1, Ala8-AII), were infused in six normal volunteers on high, regular and low sodium diets. The agonist and antagonist activities of these AIIA on blood pressure (BP), plasma aldosterone concentration (PAC), creatinine clearance and plasma renin activity were examined. Both AIIA had agonistic pressor activities in subjects on high and regular sodium diets, [Sar1, Ile8]-AII being more potent than [Sar1, Ala8]-AII. Both AIIA caused similar elevation of PAC in subjects on high and regular sodium diets, and an equally fall in PAC in subjects on a low sodium diet. Both AIIA strongly antagonized the rise in BP, the increase in PAC and the reduction of Ccr induced by AII administration in subjects on all three sodium diets. The results indicate that both AIIA can be used to examine the activity of the renin-angiotensin system in patients with hypertension, and they also suggest that AII interaction with its receptors differs in different target tissues.
Similar content being viewed by others
References
Haber E (1976) The role of renin in normal and pathological cardiovascular homeostasis. Circulation 54: 849–861
Davis JO, Freeman RH, Johnson JA, Spielman WS (1974) Agents whick block the action of the renin-angiotensin system. Circ Res 34: 279–285
Hollenberg NK, Williams GH, Burger B, Ishikawa I, Adams DF (1976) Blockade and stimulation of renal, adrenal and vascular angiotensin II receptors with 1-Sar, 8-Ala angiotensin II in normal man. J Clin Invest 57: 39–46
Williams GH, McDonnell LM, Raux MG, Hollenberg NK (1974) Evidence for different angiotensin II receptors in rat adrenal glomerulosa and rabbit vascular smooth muscle cells: Studies with competitive antagonists. Circ Res 34: 384–390
Ogihara T, Yamamoto T, Kumahara Y (1974) Clinical application of synthetic angiotensin II analogue. Jpn Circ J 38: 997–1003
Brunner HB, Gavras H, Laragh JH, Keenan R (1973) Angiotensin II blockade in man by Sar1, Ala8-angiotensin II for understanding and treatment of high blood pressure. Lancet 2: 1045–1048
Streeten DHP, Anderson GH, Freiberg JM, Dalakos TG (1975) Use of an angiotensin II antagonist (Saralasin) in the recognition of “angiotensinogenic” hypertension. N Engl J Med 292: 657–662
Case DB, Wallace JM, Keim HJ, Sealey JE, Laragh JH (1976) Usefulness and limitations of saralasin, a partial competitive agonist of angiotensin II, for evaluating the renin and sodium factors in hypertensive patients. Am J Med 60: 825–836
Ogihara T, Hata T, Mikami H, Mandai T, Kumahara Y (1977) Effects of two angiotensin II analogues on blood pressure in normal subjects with various sodium balances. Life Sci 20: 1855–1862
Siegal S (1956) Nonparametric statistics for the behavioural science. McGraw-Hill, London, pp 75–83
Bravo EL, Khosla MC, Bumpus FM (1976) Comparative studies of the humoral and arterial pressure responses to Sar1, Ala8-, Sar1, Ile8- and Sar1, Thr8-angiotensin II in the trained, unanaesthetized dog. In: Stokes GS, Edwards KDG (eds) Progress in biochemical pharmacology. Drugs affecting the renin-angiotensin-aldosterone system. Karger, Basel, pp 33–40
Beckerhoff R, Uhlschmid G, Furner J, Nussberger J, Schmid U, Vetter W, Siegenthaler W (1975) In vivo effects of angiotensin antagonist on plasma aldosterone in the dog. Eur J Pharmacol 34: 363–367
Steele JM Jr, Lowenstein J (1974) Differential effects of an angiotensin II analogue on pressor and adrenal receptors in the rabbit. Circ Res 35: 592–600
Hollenberg NK, Chenitz WR, Adams DF, Williams GH (1974) Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man. J Clin Invest 54: 34–42
Sugawara S, Zimmerman BG (1978) Influence of angiotensin antagonists on renal vascular resistance and prostaglandin E release. Clin Exp Hypertension 1: 11–24
Blair-West JR, Coghlan JP, Denton DA, Funder JW, Scoggins BA, Wright RD (1971) Inhibition of renin secretion by systemic and intraarenal angiotensin infusion. Am J Physiol 220: 1309–1315
Jurker RK, Page IH, Bumpus FM (1974) Antagonists of angiotensin II. In: Page IH, Bumpus FM (eds) Angiotensin. Springer, Berlin Heidelberg New York, pp 162–169
Beckerhoff R, Uhlschmid G, Vetter WJ, Armbruster H, Nussberger J, Schimid U, Siegenthaler W (1975) The effect of the angiotensin analogue 1-Sar, 8-Ile-angiotensin II on aldosterone and renin secretion in dogs. Acta Endocrinol 193: (Suppl. I) 134
Johnson JA, Davis JO (1973) Angiotensin II: Important role in the maintenance of arterial blood pressure. Science 12: 906–907
Bravo EL, Khosla MC, Bumpus FM (1975) Vascular and adrenocortical responses to a specific antagonist of angiotensin II. Am J Physiol 228: 110–114
Kaplan NM, Silah JS (1964) The effect of angiotensin II on the blood pressure in humans with hypertensive disease. J Clin Invest 43: 659–669
Williams GH, Hollenberg NK, Braley LM (1976) Influence of sodium intake on vascular and adrenal angiotensin II receptors. Endocrinology 98: 1343–1350
Devynck MK, Meyer P (1976) Angiotensin receptors in vascular tissue. Am J Med 61: 758–767
Slack BL, Ledingham JH (1976) The influence of sodium intake on the pressor response to angiotensin II in the unanaesthetized rat. Clin Sci Mol Med 50: 285–291
Wallace JM, Case DB, Laragh JH, Keim HJ, Drayer JIM, Sealey JE (1979) The immediate pressor response to Saralasin in man: A test of angiotensin II receptor vacancy. Circ Res 44: 38–44
Hata T, Ogihara T, Mikami H, Nakamaru M, Maruyama A, Mandai T, Kumahara Y (1978) Comparison of the biological effects of two angiotensin II analogues in hypertensive patients with sodium depletion. Life Sci 22: 1955–1962
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hata, T., Ogihara, T., Mikami, H. et al. Effects of two angiotensin II analogues on blood pressure, plasma aldosterone concentration, plasma renin activity and creatinine clearance in normal subjects on different sodium intakes. Eur J Clin Pharmacol 18, 295–299 (1980). https://doi.org/10.1007/BF00561385
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00561385